Concepedia

Author

Kamilla Danebod

Aarhus University HospitalORCID

Also Known As

Danebod, K., Danebod, Kamilla, K Danebod, K. Danebod, Kamilla Danebod, Prado, Monica

34

Publications

462

Citations

10

H-Index

3

Concepts

All Affiliations

Aarhus University HospitalHerlev HospitalRigshospitaletZealand University Hospital KøgeGentofte Hospital
KD

About

Kamilla Danebod is an author at Aarhus University Hospital specializing in medicine, pediatrics, and longevity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

64

2

Longevity

1

1

64

3

Pediatrics

1

1

64

Kamilla Danebod

×

9

Publications

395

Citations

9

H-Index

YearCitations

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

Bente Glintborg, Anne Gitte Loft, Emina Omerovic,

Annals of the Rheumatic Diseases

2018

153

Thymus Size at 6 Months of Age and Subsequent Child Mortality

May‐Lill Garly, Sisse Lecanda Trautner, Charlotte Marx,

The Journal of Pediatrics

2008

64

Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry

Bente Glintborg, Dorte Vendelbo Jensen, Sara Engel,

RMD Open

2021

59

Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial

Hafsah Nabi, Stylianos Georgiadis, Anne Gitte Loft,

Annals of the Rheumatic Diseases

2021

30

Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases

Bente Glintborg, Dorte Vendelbo Jensen, Lene Terslev,

The Journal of Rheumatology

2022

27

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

Bente Glintborg, IJ Sørensen, A.G. Loft,

Annals of the Rheumatic Diseases

2017

23

One-year clinical outcomes in 1623 patients with inflammatory arthritis who switched from originator to biosimilar Etanercept - an observational study from the Danish Danbio Registry

Bente Glintborg, Emina Omerovic, Kamilla Danebod,

VBN Forskningsportal (Aalborg Universitet)

2017

15

POS1170 SELF-PROTECTION STRATEGIES, HEALTH BEHAVIOR AND DISEASE ACTIVITY DURING THE FIRST WAVE, RE-OPENING AND SECOND WAVE OF THE COVID-19 PANDEMIC IN >7000 DANISH PATIENTS WITH INFLAMMATORY ARTHRITIS

Bente Glintborg, Dorte Vendelbo Jensen, Sara Engel,

Annals of the Rheumatic Diseases

2021

13

Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis

Bente Glintborg, Dorte Vendelbo Jensen, Lene Terslev,

Lara D. Veeken

2021

11

Page 1